| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |